Orland, CA, United States of America

Miles R Chedekel

This inventor holds 1 USPTO granted patent. Top assignee: Biosource Technologies, Inc.. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miles R Chedekel: Innovator in Melanin Production

Introduction

Miles R Chedekel is an accomplished inventor based in Orland, CA (US). He is known for his significant contributions to the field of biotechnology, particularly in the production of melanins. His innovative approach has led to advancements in the methods of producing these important compounds.

Latest Patents

Chedekel holds a patent for "Melanin production by transformed organisms." This invention outlines a process for producing melanins, their precursors, and analogues. The process enables the production of melanins in amounts greater than about 3.3 grams wet weight per liter of growth medium. The enhanced production can be achieved by manipulating the constituents of the growth medium, altering fermentation conditions, genetically engineering microorganisms, or mutating these microorganisms.

Career Highlights

Miles R Chedekel has made a notable impact in the biotechnology sector through his work at Biosource Technologies, Inc. His research and innovations have contributed to the understanding and application of melanin production, which has potential uses in various industries.

Collaborations

Chedekel has collaborated with esteemed colleagues such as Genadie G Sverlow and Thomas H Turpen. These partnerships have fostered a collaborative environment that enhances research and development in their field.

Conclusion

Miles R Chedekel's work in melanin production exemplifies the innovative spirit of modern biotechnology. His contributions continue to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…